Voyager Therapeutics Inc (VYGR)
Operating Cash Flow (Statement)
-$120.57M
TTM · Period ending: · USD
VYGR Operating Cash Flow (Statement)
Latest reported-$120.57Mperiod ending
Latest reported-$120.57Mperiod ending
VYGR TTM Cash from Operations (-$11.92M → -$120.57M)
TTM operating cash flow (statement)
High-resolution chart · PNG
VYGR operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -120,572,000 | |
| -127,991,000 | |
| -132,467,000 | |
| -116,733,000 | |
| -113,653,000 | |
| -111,972,000 | |
| -15,310,000 | |
| -24,541,000 | |
| -17,624,000 | |
| 13,121,000 | |
| 77,919,000 | |
| 89,435,000 | |
| 94,280,000 | |
| 76,630,000 | |
| -12,509,000 | |
| 10,930,000 | |
| 6,427,000 | |
| 2,195,000 | |
| -53,525,000 | |
| -86,697,000 | |
| -90,728,000 | |
| -89,212,000 | |
| -96,716,000 | |
| -98,099,000 | |
| -94,938,000 | |
| -105,294,000 | |
| 48,666,000 | |
| 47,678,000 | |
| 51,610,000 | |
| 60,665,000 | |
| -15,887,000 | |
| -6,373,000 | |
| -4,613,000 | |
| 1,554,000 | |
| -61,350,000 | |
| -59,608,000 | |
| -53,910,000 | |
| -47,289,000 | |
| -42,482,000 | |
| -38,947,000 | |
| -35,508,000 | |
| -32,776,000 | |
| 41,299,000 | |
| 46,064,000 | |
| 50,485,000 | |
| 55,204,000 | |
| -11,918,000 |